56.10MMarket Cap-2103P/E (TTM)
1.2556High1.2100Low9.74KVolume1.2400Open1.2600Pre Close11.97KTurnover0.04%Turnover RatioLossP/E (Static)45.98MShares4.200052wk High-2.28P/B33.19MFloat Cap0.880052wk Low--Dividend TTM27.20MShs Float17.8400Historical High--Div YieldTTM3.62%Amplitude0.8800Historical Low1.2290Avg Price1Lot Size
Theratechnologies Stock Forum
NEWS
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
05/02/2024 - 04:30 AM
First long-term data presentation from Parts 1 and 2 of the Phase 1 clinical trial of sudocetaxel zendusortide in solid tumors
Part 3 of Phase 1 trial in advanced ovarian cancer is ongoing
MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the...
$Heron Therapeutics(HRTX.US)$ : Approved 1/23 🎉
⇒ ZYNRELEF
⇒ Postoperative pain
⇒ sNDA
⇒ PDUFA: 01/23/24
$Liquidia(LQDA.US)$ : NDA review ongoing 🤔
⇒ YUTREPIA
⇒ PH-ILD
⇒ NDA
⇒ PDUFA: 01/24/24
$Theratechnologies(THTX.US)$ : CRL 1/24 🙁
⇒ F8 Formulation of Tesamorelin
⇒ Excess abdominal fat in adults w/ HIV
⇒ sBLA
⇒ PDUFA: 01/22/24
$Sanofi(SNY.US)$ & $Regeneron Pharmaceuticals(REGN.US)$ : Approved 1/25 🎉
⇒ Dupixent
⇒ Eosinophilic esophagitis (pedia)
⇒ sB...
4 MINUTES AGO, 7:00 AM EST
MONTREAL, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX:TH) (NASDAQ:THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, has received correspondence from the U.S. Food and Drug Administration (FDA) regarding the Company's supplemental Biolo...
Hope miracle happens suddenly shows up an acquisition news like $Gracell Biotechnologies(GRCL.US)$ by ...
No comment yet